330 related articles for article (PubMed ID: 7001662)
1. [Immunologic cell markers in lymphoproliferative diseases].
Samoĭlova RS
Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
[No Abstract] [Full Text] [Related]
2. [Membrane markers in chronic lymphoproliferative diseases].
Matutes E; San Miguel JF; Catovsky D
Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
[No Abstract] [Full Text] [Related]
3. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
Aisenberg AC
N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
[No Abstract] [Full Text] [Related]
4. [Immunologic diagnosis of variants of chronic lymphoid leukemia and lymphosarcomas].
Samoĭlova RS; Ol'shevskaia EV; Polianskaia AM
Ter Arkh; 1981; 53(11):73-8. PubMed ID: 7041315
[No Abstract] [Full Text] [Related]
5. Detection of T and B cell populations in some lymphoproliferative disorders.
Herzog P; Stöckbauer P
Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
[TBL] [Abstract][Full Text] [Related]
6. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sézary's syndrome, and other lymphoid leukemias.
Said JW; Pinkus GS
Cancer; 1981 Dec; 48(12):2630-42. PubMed ID: 6975649
[TBL] [Abstract][Full Text] [Related]
7. [Immunoblastic sarcoma and related lymphoproliferative diseases (proceedings)].
Marmont A; Damasio E; Santini G; Carella M
Minerva Med; 1977 Oct; 68(51):3515-6. PubMed ID: 303751
[No Abstract] [Full Text] [Related]
8. Phenotypic and functional characterization of human malignant T cells.
Harden EA; Haynes BF
Semin Hematol; 1985 Jan; 22(1):13-26. PubMed ID: 3918348
[TBL] [Abstract][Full Text] [Related]
9. [Surface markers of T and B lymphocytes: I. General view and acute lymphoblastic leukaemia (ALL) (author's transl)].
Tomić BL
Lijec Vjesn; 1980 Nov; 102(11):643-6. PubMed ID: 7024694
[No Abstract] [Full Text] [Related]
10. Cell markers in lymphomas and leukemias.
Bowman WP; Melvin S; Mauer AM
Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
[No Abstract] [Full Text] [Related]
11. Surface markers in chronic lymphoid leukemias of B cell type.
Caligaris-Cappio F; Janossy G
Semin Hematol; 1985 Jan; 22(1):1-12. PubMed ID: 3881823
[No Abstract] [Full Text] [Related]
12. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
Cohnen G; Augener W; Douglas SD; König E; Brittinger G
Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
[No Abstract] [Full Text] [Related]
13. Cell surface phenotype in lymphoproliferative disease.
Aisenberg AC; Wilkes BM; Long JC; Harris NL
Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
[No Abstract] [Full Text] [Related]
14. [Surface marker of T- and B-leukemic cells and classification of lymphocyte proliferative neoplasms].
Kikuchi K; Ishii Y; Koshiba H
Nihon Rinsho; 1976 May; 34(5):900-11. PubMed ID: 789939
[No Abstract] [Full Text] [Related]
15. Use of solid-phase radioimmunoassay specific for human IgG or human C3b to detect Fc gamma or C3b receptors on human lymphoblastoid cell surfaces.
Frade R; Barel M; Charriaut C
Methods Enzymol; 1983; 93():155-63. PubMed ID: 6223196
[No Abstract] [Full Text] [Related]
16. [Protein kinase activity in lymphoid cells in various forms of lymphoproliferative disorders].
Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
Vopr Med Khim; 1991; 37(6):30-3. PubMed ID: 1687494
[TBL] [Abstract][Full Text] [Related]
17. Identifying and enumerating human T and B lymphocytes. A review of techniques, problems, and progress in clinical studies.
Dwyer JM
Prog Allergy; 1976; 21():178-260. PubMed ID: 794886
[No Abstract] [Full Text] [Related]
18. T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatment.
Parkinson DR; Mier JW
Clin Immunol Rev; 1983; 2(1):59-121. PubMed ID: 6349892
[No Abstract] [Full Text] [Related]
19. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
[No Abstract] [Full Text] [Related]
20. [T-cell neoplasms with helper or suppressor activity].
Rupniewska ZM
Acta Haematol Pol; 1981; 12(1):53-61. PubMed ID: 6458988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
